SELLAS Life Sciences Group, Inc. Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
SELLAS Life Sciences Group, Inc. (SLS) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2017-03-15
- SELLAS Life Sciences Group, Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2016 was $0.00.
- SELLAS Life Sciences Group, Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2015 was -$4.55M.
- SELLAS Life Sciences Group, Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2014 was $0.00.
- SELLAS Life Sciences Group, Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2013 was $0.00.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 |
| 2015-12-31 | -$4.55M 10-K · filed 2017-03-15 |
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
| 2013-12-31 | $0.00 10-K/A · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |